Droz JP - Search Results

1

[Value of high-dose chemotherapy followed by bone marrow autograft in non-seminomatous germinal tumor with poor prognosis. Results of the combination of cisplatinum, etoposide and cyclophosphamide (PEC protocol)].

Baume D, Pico JL, Droz JP, Ostronoff M, Azab M, Gilles E, Ghosn M, Salloum E, Gouyette A, Beaujean F, et al. Baume D, et al. Among authors: droz jp. Bull Cancer. 1990;77(2):169-80. Bull Cancer. 1990. PMID: 2156588 French.

2

A phase II trial of early intensive chemotherapy with autologous bone marrow transplantation in the treatment of poor prognosis non seminomatous germ cell tumors.

Droz JP, Pico JL, Ghosn M, Kramar A, Rey A, Ostronoff M, Baume D. Droz JP, et al. Bull Cancer. 1992;79(5):497-507. Bull Cancer. 1992. PMID: 1421710 Clinical Trial.

3

Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancer.

Droz JP, Pico JL, Ghosn M, Gouyette A, Baume D, Piot G, Ostronoff M, Theodore C, Beaujean F, Hayat M. Droz JP, et al. Eur J Cancer. 1991;27(7):831-5. doi: 10.1016/0277-5379(91)90127-y. Eur J Cancer. 1991. PMID: 1718349 Clinical Trial.

4

Phase II trial of ifosfamide in the treatment of metastatic hormone-refractory patients with prostatic cancer.

Mahjoubi M, Azab M, Ghosn M, Theodore C, Droz JP. Mahjoubi M, et al. Among authors: droz jp. Cancer Invest. 1990;8(5):477-81. doi: 10.3109/07357909009012071. Cancer Invest. 1990. PMID: 2124944 Clinical Trial.

5

[Salvage chemotherapy of non-seminomatous germ cell tumors. Phase II trial of a combination of etoposide, ifosfamide and high-dose cisplatin].

Ribrag V, Droz JP, Bouleuc C, Theodore C, Ghosn M, Pico JL, Azab M, Ostronoff M, Hayat M. Ribrag V, et al. Among authors: droz jp. Presse Med. 1990 Jul 7-14;19(27):1263-6. Presse Med. 1990. PMID: 2143824 French.

6

Phase II trial of methyl-gag and melphalan in metastatic adult renal cell carcinoma.

Guimaraes JL, Ghosn M, Ostronoff M, Azab M, Theodore C, Droz JP. Guimaraes JL, et al. Among authors: droz jp. Cancer Invest. 1990;8(6):623-4. doi: 10.3109/07357909009018930. Cancer Invest. 1990. PMID: 2292054 Clinical Trial.

7

Salvage therapy with methyl-gag, high-dose Ara-C, M-Amsa, and ifosfamide (MAMI) for recurrent or refractory lymphoma.

Hayat M, Ostronoff M, Gilles E, Zambon E, Baume D, Moran A, Carde P, Droz JP, Pico JL. Hayat M, et al. Among authors: droz jp. Cancer Invest. 1990;8(1):1-5. doi: 10.3109/07357909009017540. Cancer Invest. 1990. PMID: 2350713

8

[Chemotherapeutic intensification in germ cell tumors].

Droz JP, Pico JL, Ghosn M, Ostronoff M, Azab M, Theodore C, Hayat M. Droz JP, et al. Bull Cancer. 1990;77(4):349-54. Bull Cancer. 1990. PMID: 2354250 French.

9

Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high-risk gestational trophoblastic tumors.

Azab M, Droz JP, Theodore C, Wolff JP, Amiel JL. Azab M, et al. Among authors: droz jp. Cancer. 1989 Nov 1;64(9):1829-32. doi: 10.1002/1097-0142(19891101)64:9<1829::aid-cncr2820640912>3.0.co;2-g. Cancer. 1989. PMID: 2477136

10

Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumors.

Droz JP, Ribrag V, Ghosn M, Guimares J, Theodore C, Azab M, Ostronoff M, Mahjoubi M, Moran A, Pico J, et al. Droz JP, et al. Prog Clin Biol Res. 1989;303:739-47. Prog Clin Biol Res. 1989. PMID: 2550949 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

470 results

Search Page

Filters